Company news

31.08.10
Lab21 launches new commercial companion diagnostic service for HIV tropism in UK →

26.08.10
Lab21 licences pharmacogenetic IP for CES-1 from MUSC →

01.06.10
Lab21 achieves first product registration in China →

24.05.10
Lab21 and Virco partner to offer UK-based HIV-1 genotyping services →

18.12.09
Lab21 acquires US nanotechnology company and establishes Lab21 Inc. in South Carolina →

26.11.09
Lab21 acquires personalised medicine diagnostic services business →

17.11.09
Lab21 launches new high sensitivity immunodiagnostic system for CMV antibody detection →

15.09.09
Lab21 signs agreement with AstraZeneca to provide genetic testing service in lung cancer →

04.08.09
Lab21 Ltd to Provide AdnaGen’s CE-Marked System for the Detection and Analysis of Circulating Tumor Cells (CTCs) in the United Kingdom and Ireland. →

21.07.09
Lab21 announces publication of syphilis diagnostic patent →

22.06.09
Lab21 expands its predisposition oncology service portfolio with A NEW TEST TO DETERMINE SMOKERS’ LUNG CANCER RISK →

16.06.09
Lab21 partners with Innogenetics to build comprehensive HCV drug resistance IP portfolio →

27.05.09
Lab21 expands oncology portfolio with 5-FU personalised chemotherapy management service →

20.05.09
Lab21 acquires Plasmatec Laboratory Products from Axis-Shield →

24.03.09
Lab21’s NP Tech division gains CPA accreditation →

17.03.09
Lab21 raises a further £1.3m and Dr Kai Deusch joins the Board →

03.03.09
Lab21 Acquires Biotec Laboratories →

27.01.09
Lab 21 and Breasthealth UK form partnership for breast health management →

23.12.08
Lab21 successfully closes funding round of £2.2m →

16.12.08
Lab21 launches new 3 day service to identify Fungal Pneumonia →

07.11.08
Lab21 Expands International Business with Launch into India with a Million Dollar Syphilis Testing →

17.10.08
Lab21 spins out environmental monitoring business to Cogent Environmental Ltd →

09.10.08
Lab21 to market deCODE BreastCancer™, a Genetic Test to Screen for Risk of the Most Common Forms of Breast Cancer →

12.08.08
Lab21 expands its range of cardiovascular genetic tests with Clinical Data, Inc. →

12.08.08
Lab21 to market deCODE tests for assessing risk of common diseases →

16.07.08
Lab21 expands companion diagnostic cancer testing service internationally →

25.06.08
Lab21 expands cancer gene testing service →

24.06.08
Lab 21 Environmental helping to provide safe drinking water following Chinese earthquake →

20.03.08
Lab21 acquires NPTech Ltd and appoints corporate advisors for European M&A activity →

17.03.08
Predictive genetic test for bowel cancer treatment is introduced in the UK →

21.02.08
Lab21 signs a license with Celera for one of the first diagnostic tests for cirrhosis risk in hepatitis C patients →

15.01.08
Lab21 spearheads introduction of improved diagnostic assays for healthcare and environmental management →